NEET paper leak: CBI questions director of coaching centre in Maharashtra's LaturThe Central Bureau of Investigation is actively probing the NEET (UG) paper leak. Officials questioned Shivraj Motegaonkar, director of Ren...
NEET 2026 paper leak: Rajasthan Police find mock test had over 100 questions matching actual exam paperRajasthan Police's Special Operations Group is investigating alleged irregularities in the NEET UG 2026 examination after the NTA received ...
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommendedBiocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges im...
Biocon Q4 Results: Net profit down 57% at Rs 198.6 croreBiocon Ltd reported a 56.8% drop in Q4 net profit to Rs 198.6 crore, impacted by an Rs 80.4 crore exceptional item. Despite this, consolida...
Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: ReportBiocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder...
Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps downBiocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will...
'Biocon Biologics to integrate Viatris' US biosimilar business by Q2 end'Biocon Biologics plans to complete the integration of Viatris' biosimilar business in North America by the end of Q2FY24, which is ahead of...
Maharashtra: Rebellion, a common thread running through Congress's Thorat and Tambe familiesEarlier on Thursday, Sudhir Tambe, official Congress candidate for the biennial elections to the Upper House, announced withdrawal from the...
Biocon Biologics appoints Shreehas Tambe as MD & CEOTambe has been with Biocon since 1997 and has held diverse leadership and operational roles. Over the past 25 years, he has helped build an...
Sebi bans Biocon senior executive from securities marketThe regulator on Thursday restrained Shreehas P Tambe, senior Vice President of Biocon, from associating himself with any listed company an...
Sebi bars Biocon's official from market for 3 months in insider trading caseSenior vice president of Biocon, Shreehas P Tambe, being an insider traded in the shares of the firm between December 19-27, 2017, in viola...
Biocon Biologics promotes Shreehas Tambe as deputy CEOA Biocon veteran, Shreehas Tambe joined the company in 1997 and has more than 20 years of leadership experience in operational and strategi...
IS recruit Tabrez Tambe had deposited money into brother's a/c for air travel: ATS officialsTambe had had left in January along with his friend Ali Al Shahri, a Saudi national.
How IPL changed lives: Spinner who turned winnerPravin Tambe’s cricketing dreams went unfulfilled for years, till he was picked by Rajasthan at the young age of 41